MYC and diffuse large B-cell lymphoma: We first focused on the MYC translocation positive DLBCL, subdivided according to the number (1 or 2) of additional genetic abnormalities regardless of their nature, and examined whether the number of additional genetic abnormalities impacted on patient survival.